Prenetics

Avi Lasarow is the CEO of Prenetics. To contact Avi Lasarow email at [email protected] or [email protected]. Or you may call +44.8454632602 or +44.8454634653

The decision makers in Prenetics are Angela Cheung, Bayju Thakar, Ciara Moss, etc. Click to Find Prenetics decision makers emails.

Prenetics specializes in precision oncology by providing advanced genomic testing solutions that help identify the most effective treatment options for cancer patients. Our services include comprehensive genomic profiling, which analyzes a patient's tumor DNA to detect mutations and alterations that can inform targeted therapies. Additionally, we offer pharmacogenomics testing to understand how a patient's genetic makeup can influence their response to specific medications, ensuring personalized treatment plans.

Prenetics' DNA testing involves collecting a sample, typically through a simple saliva or blood draw. This sample is then analyzed in our state-of-the-art laboratories using advanced genomic technologies. The results provide insights into an individual's genetic predispositions, potential health risks, and responses to various medications. Our tests are designed to empower patients and healthcare providers with actionable information for better health management and personalized treatment strategies.

Prenetics supports a variety of industries, primarily focusing on healthcare and pharmaceuticals. In the healthcare sector, we collaborate with hospitals, clinics, and healthcare providers to enhance patient care through personalized medicine. In the pharmaceutical industry, we partner with companies to facilitate drug development and clinical trials by providing genomic insights that can optimize treatment efficacy and safety. Additionally, our solutions are beneficial for wellness and preventive health sectors, helping individuals understand their genetic risks and make informed lifestyle choices.

Pharmacogenomics testing is a branch of personalized medicine that studies how an individual's genetic makeup affects their response to medications. Prenetics offers this testing to help healthcare providers tailor drug prescriptions based on a patient's genetic profile, minimizing adverse drug reactions and maximizing therapeutic efficacy. This approach is crucial as it leads to more effective treatment plans, reduces trial-and-error prescribing, and enhances overall patient safety and satisfaction.

Yes, Prenetics' genomic and precision oncology services are designed to be easily integrated into existing healthcare systems. We provide comprehensive support to healthcare providers, including training, resources, and technology solutions that facilitate the incorporation of genomic testing into routine patient care. Our goal is to enhance the capabilities of healthcare professionals, enabling them to leverage genomic insights for improved patient outcomes.

Prenetics takes the privacy and security of genetic data very seriously. We adhere to strict regulatory standards and best practices for data protection, including compliance with HIPAA and GDPR regulations. All genetic data is encrypted and stored securely, with access limited to authorized personnel only. We also provide patients with clear information about how their data will be used and ensure that consent is obtained before any testing is conducted. Our commitment to data privacy helps build trust with our patients and partners.